MedPath

INNOVAR INJ

INNOVAR INJ

Discontinued
DIN Number

00554243

Drug Class

Human

Market Date

Dec 31, 1982

Company
HC

janssen pharmaceutica, division of janssen-ortho inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00554243
AIG Number0201835001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
N01AH51 FENTANYL, COMBINATIONS
Product Specifications
Dosage FormLiquid
Route of AdministrationIntramuscular ,  Intravenous
AHFS Classification28:24.92
Health Canada Classification

ACTIVE INGREDIENTS (2)

DROPERIDOLActive
Strength: 2.5 MG / ML
Monograph: DROPERIDOL
FENTANYL CITRATEActive
Strength: .05 MG / ML
Monograph: FENTANYL CITRATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.